Aequim Alternative Investments’s Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 GLS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-82,917
Closed -$738 129
2022
Q4
$738 Hold
82,917
﹤0.01% 133
2022
Q3
$4K Hold
82,917
﹤0.01% 135
2022
Q2
$9K Buy
82,917
+32,917
+66% +$7.73K ﹤0.01% 139
2022
Q1
$11K Buy
+50,000
New +$11.7K ﹤0.01% 150

Other funds holding GLS.WS

Aequim Alternative Investments's GLS.WS Position: Q1 2023 in Review

Aequim Alternative Investments sold out of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) in Q1 2023, closing a stake of 82,917 shares — an estimated $738 sold.

Aequim Alternative Investments first reported a position in GLS.WS in Q1 2022 and held it in 4 quarters. The position peaked at $11K in Q1 2022. 4 funds tracked by Wall St. Rank hold GLS.WS as of Q1 2023.

  • Aequim Alternative Investments reported no remaining Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
  • Aequim Alternative Investments sold 82,917 Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q1 2023, an estimated $738.
  • Aequim Alternative Investments first reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q1 2022 and held it in 4 quarters.
  • Aequim Alternative Investments's Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $11K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q1 2023.

Based on Aequim Alternative Investments's 13F filing for Q1 2023, filed 12 May 2023.